Mirae Asset Global Investments’s Indivior Pharmaceuticals INDV Stock Holding History

Mirae Asset Global Investments’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$224K	Sell	5,453 -9,050	-62%	-$328K	﹤0.01%	1104
2026 Q1	$442K	Sell	14,503 -7,717	-35%	-$255K	﹤0.01%	955
2025 Q4	$797K	Buy	22,220 +7,670	+53%	+$234K	﹤0.01%	932
2025 Q3	$351K	Buy	14,550 +9,730	+202%	+$204K	﹤0.01%	1047
2025 Q2	$71K	Buy	4,820 +666	+16%	+$7.76K	﹤0.01%	1199
2025 Q1	$39.7K	Sell	4,154 -389	-9%	-$4.09K	﹤0.01%	1280
2024 Q4	$56.2K	Buy	+4,543	New	+$46.7K	﹤0.01%	1253

Other funds holding INDV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Mirae Asset Global Investments's INDV Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Indivior Pharmaceuticals (INDV) stake by 62% in Q2 2026, selling an estimated $328K and leaving 5,453 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #1104.

Mirae Asset Global Investments first reported a position in INDV in Q4 2024 and has held it in 7 quarters since. The position peaked at $797K in Q4 2025. 125 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

Mirae Asset Global Investments held 5,453 shares of Indivior Pharmaceuticals worth $224K as of Q2 2026.
Mirae Asset Global Investments sold 9,050 Indivior Pharmaceuticals shares in Q2 2026, an estimated $328K.
Indivior Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1104 holding.
Mirae Asset Global Investments first reported a position in Indivior Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Mirae Asset Global Investments's Indivior Pharmaceuticals position peaked at $797K in Q4 2025.
125 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.